Lei et al., (2019) [93] |
To study the effectiveness of self-healing gelatin |
In vitro |
L929 cellsand L02 cells |
24 h and 72 h |
-
‒
FTIR showed absorption band at 2 935 cm−1 and amide I band at 1640 cm−1.
-
‒
Healing effectiveness was at 50% at 40th and 90% at 60 min.
-
‒
Pore size ∼100 μm was seen.
-
‒
Equilibrium swelling ratio was ~1.28.
-
‒
The temperature at the maximum rate of weight loss 308.7 °C.
-
‒
Cell viability was >90% up to 72 h.
-
‒
Absence of cytotoxicity was recorded.
|
The fabricated self-healing gelatin has application prospects in biomedical fields. |
Akhavan-Kharazian et al., (2019) [94] |
To characterize gelatin as a potential agent for wound healing |
In vitro |
Human fibroblast cells |
7 days |
-
‒
FTIR showed absorption band at 3264 cm −1 (amide A), 1675 cm −1 (amide I), 1542 cm −1 and (amide II).
-
‒
Addition of chitosan increased the swelling percentage.
-
‒
The elastic modulus, tensile strength and elongation at break were 1450 ± 31 MPa, 47.3 ± 2.1 3 MPa and 5 ± 0.2 %.
-
‒
WVTR result was 46.1 g/m2/h.
-
‒
A 16 mm diameter of zone of inhibition was recorded against Escherichia Coli.
-
‒
Good adhesion of fibroblast cells and viability was seen up to 7 days.
|
Gelatin has the potential to be integrated as a wound healing material. |
Hsu et al., (2019) [95] |
To study the efficacy of gelatin for wound healing in diabetic mice |
In vivo |
Male C57BL/6 J Narl mice |
Up to 10 days |
-
‒
Porous structure was in the range of 20 µm to 300 µm.
-
‒
FTIR showed absorption bands at 1650 cm−1 and 1545 cm−1 for amide I and amide II, respectively.
-
‒
The degradation rate increased proportionally to the amount of collagenase.
-
‒
Thick granulation tissues, increased re-epithelization and blood vessel formation were observed in the treated group.
|
Gelatin is capable of contributing to diabetic wound healing. |
Nikpasand et al., (2019) [96] |
To access the outcome of gelatin nanocomposite in wound healing |
In vivo |
50 male rats |
Up to 21 days |
-
‒
Wound contraction was seen over time starting from day 6.
-
‒
Re-epithelization and neovascularization was seen in the experimental group.
-
‒
High level of mononuclear cells polymorphonuclear cells and proliferation of fibroblast cell was seen.
-
‒
Hydroxyproline content was recorded at 97.88 ± 3.77 mg g−1 indicating a high level of Col deposition.
|
Gelatin nanocomposite accelerates wound healing. |
Enrione et al., (2018) [103] |
To study the efficacy of salmon gelatin in wound healing |
In vivo |
6 Orictholagus cuniculus rabbits |
Not specified |
-
‒
The pore size was 185.2 ± 27.1 µm
-
‒
Young modulus, stress at break and strain at break were 150.0 ±17.3 MPa, 316.8 ± 18.4 MPa and 2.48 ± 0.99%, respectively.
-
‒
DSC was recorded at 318.1 ± 0.5 K.
-
‒
Up to 93% of wound closure by week 4 was seen.
|
Salmon gelatin is a potential wound dressing material. |
Garcia-Orue et al., (2019) [104] |
To access the effectiveness of gelatin crosslinked with different agents for wound healing |
In vitro and ex vivo assay |
L-929 fibroblasts and redundant tissue from patients |
Up to 8 days |
-
‒
FTIR showed absorption bands at 1630 cm−1, 1530 cm−1, 1230 cm−1 for amide I, amide II and amide III.
-
‒
At 700% swelling equilibrium was reached.
-
‒
WVTR existed in the range of 773.7 ± 43.4 g/m2 day and 787.0 ± 50.9 g/m2.
-
‒
Absence of cytotoxicity confirmed through CCK-8 assay.
-
‒
>70% of cell viability was recorded on day 4 and day 8.
-
‒
Increase in cell proliferation markers, myofibroblast differentiation, cytokeratin 14 and 10 was seen.
|
Gelatin hydrofilm serves as a perfect biomaterial for wound dressing. |
Zeng et al., (2015) [105] |
To access the effectiveness of gelatin microcryogel for wound healing |
In vitro and In vivo |
human adipose-derived stem cells and nude mice |
Up to 11 days |
-
‒
Pore size was 400 µm width and 500 µm height.
-
‒
Swelling ratio was recorded at 23.49 ± 1.57%.
-
‒
Yong modulus was recorded at 8.25 ± 0.64 KPa.
-
‒
>65% of adherence of cells to the scaffold with 1.5 h.
-
‒
Gene expression study showed increase in vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) at 48th hour.
|
Gelatin microcryogel supports wound healing. |
Jang et al., (2017) [97] |
To analyse the effectiveness of gelatin paste containing dermal powder for wound healing |
In vitro and in vivo |
Fibroblasts and Sprague Dawley rats |
18th and 48th day |
-
‒
On 18th day, 85% of wound contraction was seen in the gelatin group.
-
‒
A thick spinous layer and hyperkeratosis was seen on day 48.
-
‒
Low level of elastic fibers and blood vessel formation was seen in the controlled group.
-
‒
No significant immune response was seen.
-
‒
Leukocyte values were 7.28 ± 3.24 and 8.78 ± 2.71 for days 18 and 48, respectively.
|
Gelatin promotes full thickness wound healing. |
Gomes et al., (2015) [106] |
To evaluate the effectiveness of gelatin in skin wound healing |
In vitro and in vivo |
human fetal fibroblasts (HFFF2) and 18 Wistar rats |
Up to week 4 |
-
‒
The porosity was recorded as 78 ± 10% with a lowest viscosity and highest conductivity.
-
‒
Gelatin scaffold was rigid with an elasticity result of 162 ± 96 MPa and brittle, ε = 9 ± 5%.
-
‒
FTIR showed 3280 cm−1, 1640 cm−1, 1530 cm−1 and 1240 cm−1 for amide A, amide I, amide II and amide III, respectively.
-
‒
Cell viability reduced to 67% on 2nd day of cell seeding.
-
‒
Continuous cell growth in gelatin scaffold was seen up to day 9.
-
‒
Cells were scattered in the gelatin scaffold which then improved in density and alignment by day 7.
-
‒
Rapid healing was recorded in in vivo study for gelatin group.
-
‒
Wound contraction, formation of new blood vessels and complete healing was achieved by week 4.
|
Gelatin scaffold supports full thickness wound healing. |